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Abstract 
Purpose: To determine whether the methanol extract of Polyopes affinis (MEPA) down-regulates the 
expression of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated BV2 microglial cells. 
Methods: The production of nitric oxide (NO) and prostaglandin E2 (PGE2) was measured by the Griess 
reagents and enzyme-linked immunosorbent assay (ELISA), respectively. Expression levels of mRNA 
and protein in LPS-stimulated BV2 microglial cells were assessed by reverse transcription-polymerase 
(RT-PCR) and Western blot analysis. Activation of nuclear factor-κB (NF-κB) was detected by 
electrophoretic mobility shift assay (EMSA). 
Results: MEPA inhibited the expression of LPS-induced pro-inflammatory mediators, NO and PGE2, as 
well as their respective genes, iNOS and COX-2, at both protein and mRNA levels, without any 
accompanying cytotoxicity. Moreover, treatment with MEPA significantly suppressed the LPS-induced 
DNA-binding activity of NF-κB, which is known as a main transcription factor for the regulation of pro-
inflammatory genes, as well as the nuclear translocation of its subunit p65 and p50, by degrading IκBα. 
MEPA increased Akt dephosphorylation which leads to suppression of the DNA-binding activity of NF-
κB in LPS-stimulated BV2 microglial cells and suppressed phosphorylation of ERK and JNK, which are 
involved in the mitogen-activated protein kinase (MAPK) signaling pathway for regulating pro-
inflammatory genes. 
Conclusion: Our results indicate that MEPA down-regulates pro-inflammatory mediators such as NO 
and PGE2 by suppressing Akt-dependent NF-κB activity as well as phosphorylation of ERK and JNK in 
LPS-stimulated BV2 microglial cells. 
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Several seaweed extracts are well-known to 
regulate immune and inflammatory responses. 
Marine algae, have been extensively studied 
since they are a rich source of novel structural 
compounds that exhibit biological activities 
against cardiac, vascular and hepatic disease; 
high blood pressure; senility; and diabetes. 
Compared to other algae such as green and 
brown algae, red algae contain a higher amount 
of proteins, carbohydrates and other nutrients 
[1,2]. Many researchers are initiating attempts to 
seek potent compounds derived from marine 
algae, which have anti-inflammatory 
characteristics [3–5]. Although Polyopes affinis, 
which is a marine red algae, has been used to 
treat diseases in adults in North-Eastern Asia, 
studies investigating its anti-inflammatory effects 
in lipopolysaccharide (LPS)-stimulated BV2 
microglial cells have not been carried out. 
 
Inflammation is the biological response to 
harmful stimuli such as autoimmune diseases, 
pathogenic infections, damaged cells and 
irritants. Thus inflammation initiates the healing 
process [6]. Inflammation increases the 
expression of inflammatory mediators such as 
nitric oxide (NO) and prostaglandin E2 (PGE2), 
which are regulated by inducible nitric oxide 
synthase (iNOS) and cyclooxygenase-2 (COX-2), 
respectively [7,8]. These inflammatory mediators 
are required for the regulation of cellular 
pathways involved in protecting against organ 
disorder, such as ischemic damage [9,10]. 
However, excessive inflammatory response can 
lead to overexpression of pro-inflammatory 
mediators, which can result in severe 
inflammatory disorders such as septic shock, 
rheumatoid arthritis, Alzheimer’s disease and 
Parkinson’s disease [10,11]. Therefore, agents 
that attenuate pro-inflammatory mediators in 
microglial cells could represent promising 
strategies to tackle brain injury and 
neurodegenerative diseases. 
 
Cell signaling pathways involve the production of 
various cytokines and inflammatory mediators. 
The nuclear factor-κB (NF-κB) pathway, in 
particular, may play a key role in such pathways 
due to its rapid activation and potency as a 
transcriptional activator [12]. Thus, aberrant NF-
κB activation is known to be a potential target 
associated with various inflammatory diseases 
[13]. According to recent studies, Akt and 
mitogen-activated protein kinases (MAPKs) lead 
to NF-κB activation by proteasome-dependent 
IκB degradation [14,15]. Therefore, inhibition of 
NF-κB activity through the Akt and MAPK 
pathways results in anti-inflammatory effects. 
In the present study, we investigated the 
methanol extract of P. affinis (MEPA)-mediated 
inhibition of NO and PGE2 expression by 
assessing the suppression of NF-κB activity in 
LPS-stimulated BV2 microglial cells. Regulation 
of NF-κB activity by MEPA is also associated 
with the inhibition of phosphorylation of Akt and 





Reagents and chemicals 
 
LPS and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide (MTT) were 
purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). Rabbit anti-human antibodies against 
iNOS, COX-2, p65, p50, phospho (p)-IκBα, and 
IκBα were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). The antibody 
against β-actin and c23 were obtained from 
Sigma. Rabbit anti-human antibodies against p-
ERK, ERK, p-p38, p38, p-JNK, JNK, p-Akt and 
Akt were obtained from cell signaling (Beverly, 
MA). Peroxidase-labeled goat anti-rabbit 
immunoglobulin was purchased from KOMA 
Biotechnology (Seoul, Republic of Korea). 
LY294002 was purchased from Calbiochem (San 
Diego, CA). Dulbecco’s modified Eagle’s medium 
(DMEM) and fetal bovine serum (FBS) were 
obtained from WelGENE Inc. (Daegu, Republic 
of Korea). MEPA was purchased from Jeju HI-
Tech Industry Development Institute (Jeju, 
Republic of Korea). Other chemicals were 
purchased from Sigma. 
 
Cell culture and viability 
 
BV2 microglia cells were cultured at 37 oC in 5% 
CO2 in DMEM supplemented with 5% FBS and 
antibiotics (WelGENE Inc., Daegu, Republic of 
Korea). In all experiments, cells were pre-treated 
with the indicated concentrations of MEPA for 1 h 
before the addition of LPS (1 µg/ml) in serum-





BV2 microglial cells (2 × 105 cells/ml) were plated 
onto 24-well plates and pre-treated with the 
indicated concentrations of MEPA for 1 h prior to 
stimulation with 1 µg/ml of LPS for 24 h. The cell 
supernatants were collected and assayed for NO 
production using Griess reagent. The samples 
were mixed with equal volume of Griess reagent 
(1% sulfanilamide in 5% phosphoric acid and 
0.1% naphthylethylenediamine dihydrochloride) 
and then incubated at room temperature for 5 
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min. The absorbance was measured at 540 nm 
on a microplate reader. Nitrite concentration was 
determined from a sodium nitrite standard curve. 
 
Measurement of PGE2 
 
The expression levels of PGE2 were measured 
by enzyme-linked immunosorbent assay (ELISA) 
kit (R&D Systems, Minneapolis, MN) according 
to the manufacturer’s instructions. BV2 microglial 
cells (2 × 105 cells/ml) were plated in 24-well 
plates and pretreated with the indicated 
concentrations of MEPA for 1 h prior to 
stimulation with 1 µg/ml of LPS for 24 h. One 
hundred microliters of culture media were 
collected for the determination of PGE2 
concentrations by ELISA. 
 
Reverse transcriptase polymerase chain 
reactions (RT-PCR) 
 
Total RNA was extracted from BV2 microglial 
cells using Easy-blue reagent (iNtRON 
Biotechnology, Sungnam, Republic of Korea) 
according to the manufacturer’ instructions. One 
microgram of RNA was reverse-transcribed using 
MMLV reverse transcriptase (Bioneer, Daejeon, 
Republic of Korea). Then, cDNA was amplified 
by PCR using specific primer iNOS (forward 5’-
cctcctccaccctaccaagt-3’ and reverse 5’-
cacccaaagtgcttcagtca-3’), COX- 2 (forward 5’-
aagacttgccaggctgaa ct-3’ and reverse 5’-
cttctgcagtccaggttcaa-3’) and β-Actin (forward 5’-
tgtgatggtgggaatgggtcag-3’ and reverse 5’-
tttgatgtcacgcacgatttcc-3’). The following PCR 
conditions were applied: COX-2 and iNOS, 25 
cycles of denaturation at 94 ºC for 30 s, 
annealing at 59 ºC for 30 s and extended at 72 
ºC for 30 s; β-actin, 23 cycles of denaturation at 
94 ºC for 30 s, annealing at 57 ºC for 30 s and 
extended at 72 ºC for 30 s. β-actin was used as 
an internal control to evaluate relative expression 
of COX-2 and iNOS. 
 
Western blot analysis 
 
Cells were harvested by scraping from the wells 
and washed twice with cold PBS. Total cell 
extracts were prepared using PRO-PREP protein 
extraction solution (iNtRON Biotechnology, 
Sungnam, Republic of Korea). Briefly, after 
treatment with the indicated concentrations of 
MEPA, cells were harvested, washed once with 
ice-cold PBS and gently lysed for 30 min in 100 
µl of ice-cold PRO-PREP lysis buffer. Lysates 
were centrifuged at 14,000 g at 4 ºC for 10 min to 
obtain the supernatants. Supernatants were 
collected and protein concentrations determined 
using a Bio-Rad protein assay kit (Bio-Rad, 
Hercules, CA). Samples were stored at -80°C or 
immediately used for Western blot analysis. The 
proteins were separated on SDS-polyacrylamide 
gels and transferred to nitrocellulose membranes 
(Schleicher & Schuell, Keene, NH). Proteins 
were detected using an enhanced chemilu-
minescence detection system (Amersham, 
Arlington Heights, IL). 
 
Electrophoretic mobility shift assay (EMSA) 
 
EMSA was carried out with the nuclear extract. 
Briefly, the preparation of nuclear extracts was 
conducted using NE-PER nuclear extraction 
reagents (Pierce, Rockford, IL). Synthetic 
complementary NF-κB-binding oligonucleotides 
(5’-AGT TGA GGG GAC TTT CCC AGG C-3’) 
(Santa Cruz Biotechnology) were 3‘-biotinylated 
using a biotin 3’-end DNA labeling kit (Pierce; 
Rockford, IL) according to the manufacturer’s 
instructions. Binding reactions were carried out 
for 20 min at room temperature in the presence 
of 50 ng/µl poly(dI-dC), 0.05% Nonidet P-40, 5 
mM MgCl2, 10 mM EDTA, and 2.5% glycerol in 
1× binding buffer (LightShift™ chemiluminescent 
EMSA kit, Pierce) using 20 fmol of biotin-end-
labeled target DNA and 10 µg of nuclear extract. 
Assays were loaded onto native 4% 
polyacrylamide gels pre-electrophoresed for 60 
min in 0.5× Tris borate/EDTA and 
electrophoresed at 100 V before being 
transferred onto a positively charged nylon 
membrane (Hybond™N+) in 0.5Tris 
borate/EDTA at 100V for 30 min. Transferred 
DNAs were cross-linked to the membrane at 120 
mJ/cm2 and detected using horseradish 
peroxidase-conjugated streptavidin (LightShift™ 





All data were derived from triplicate 
determinations. Statistical analyses were 
conducted using SigmaPlot software (version 
11.0) Values were presented as mean ± SE. 
Significant differences between the groups were 
determined using two-way ANOVA. Statistical 




Effect of MEPA on the viability of BV2 
microglial cells 
 
MTT assay was used to evaluate the cytotoxic 
effects of MEPA in BV2 microglial cells. Cells 
were treated with MEPA (0-100 µg/ml) in the 
presence or absence of LPS for 24 h, following 
which cell viability was measured. 
Concentrations of MEPA of up to 100 µg/ml 
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showed no difference in cell viability (Fig. 1). 
However, a dose of 150 µg/ml of MEPA resulted 
in 20% cytotoxicity (data not shown). These 
results indicated that MEPA does not produce 
cytotoxic effects in LPS-induced BV2 microglia 
cells at concentrations of 100 µg/ml, which was 




Fig 1: Effect of MEPA on the viability of BV2 microglial 
cells. Each value indicates mean ± SE (n = 3). 
 
Inhibition of NO production and iNOS 
expression by MEPA in LPS-stimulated BV2 
microglial cells 
 
NO production in LPS-stimulated BV2 microglial 
cells showed a ~7-fold increase (13.5 ± 1.2 µM), 
compared to the control (1.9 ± 0.2 µM). 
Pretreatment with MEPA reduced LPS-induced 
NO production in a dose-dependent manner (Fig. 
2A), 100 µg/ml of MEPA producing the strongest 
effect (3.2 ± 0.9 µM). Since NO production is 
regulated by iNOS, we next performed western 
blot and RT-PCR to assess the iNOS protein and 
mRNA levels at 24 h and 6 h, respectively, after 
treatment with LPS. Consistent with the results of 
NO production, we found that MEPA reduces 
levels of iNOS protein (Fig. 2B) and mRNA (Fig. 
2C), when compared to treatment with LPS 
alone. These results indicate that MEPA inhibits 
NO production by suppressing iNOS. 
 
Inhibition of PGE2 production and COX-2 
expression by MEPA in LPS-stimulated BV2 
microglial cells 
 
Treatment with LPS alone significantly increased 
the levels of PGE2 production (987 ± 26 pg/ml) 
when compared to the control (103 ± 13 pg/ml) 
(Fig. 3A). Pretreatment of cells with MEPA 
substantially attenuated the LPS-induced 
increase in PGE2 expression in a dose-
dependent manner, with maximal suppression 
observed at a concentration of 100 µg/ml (301 ± 
21 pg/ml). Next, to investigate the levels of COX-
2 protein and mRNA, western blot analysis and 
RT-PCR were performed. We observed a 
significant increase in the expression of COX-2 
protein and mRNA at 24 h and at 6 h, 
respectively (Fig. 3B and 3C), after treatment 
with LPS. Upon pretreatment of cells with MEPA 
for 1 h, LPS-induced COX-2 expression was 
significantly downregulated. These results 
indicate that MEPA inhibits PGE2 expression by 
suppressing COX-2. 
 
Inhibition of LPS-induced NF-κB activation by  
MEPA in BV2 microglial cells 
 
To evaluate MEPA-mediated regulation of NF-κB 
activity, we determined the DNA-binding activity 
of NF-κB and nuclear translocation of its subunits 
p65 and p50 in BV2 microglial cells. EMSA 
results showed that treatment with LPS caused a 
significant increase in the DNA-binding activity of 
NF-κB, while treatment with MEPA results in 




Fig 2: Effect of MEPA on LPS-induced NO and iNOS expression. Cells were seeded at 2 × 105 cells/ml and 
incubated with the indicated concentrations of MEPA 1 h before treatment with LPS (1.0 µg/ml) for 24 h (A and B) 
or 6 h (C). (A) NO expression was determined by the Griess assay; *p < 0.01. (B) Western blot analysis was 
performed with antibodies against iNOS. (C) RT-PCR analysis of iNOS was performed on total RNA isolated at 6 
h. β-Actin was used as an internal control for western blot analysis and RT-PCR; n = 3 
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Fig 3: Effect of MEPA on LPS-induced PGE2 and COX-2 expression. Cells were seeded at 2 × 10
5 cells/ml and 
incubated with the indicated concentrations of MEPA 6 h before treatment with LPS (1.0 µg/ml) for 24 h (A and B) 
or 6 h (C). (A) PGE2 expression was determined by ELISA performed according to the manufacturer’s 
instructions; *p < 0.01. (B) Western blot analysis was performed with antibodies against COX-2. (C) RT-PCR 
analysis  of COX-2 was performed on total RNA isolated at 6 h. β-Actin was used as an internal control for 
western blot analysis and RT-PCR; n = 3 
 
 
Fig 4: Effect of MEPA on NF-κB activity in LPS-stimulated BV2 microglial cells. Cells were pretreated with vehicle 
or the indicated concentrations of MEPA 1 h before stimulation with LPS (1.0 µg/ml) for 30 min. (A) Nuclear 
extracts were prepared and analyzed for DNA-binding activity of NF-κB using EMSA. Cytosolic (B) and nuclear 
(C) extracts were prepared to determine the levels of p65, p50, p-IκBα and IκBα by western blot analysis; β-Actin 
and c23 were internal controls. A result shown is representative of 3 independent experiments. 
 
To further investigate whether MEPA regulates 
nuclear translocation of p65 and p50, as well as 
IκB phosphorylation and degradation, we 
performed western blot analysis to evaluate 
protein expression levels. Treatment with LPS 
caused a significant decrease in levels of p65 
and p50 in the cytosolic extract (Fig. 4B), while 
increasing levels in the nuclear extract (Fig. 4C), 
suggesting that LPS induces nuclear 
translocation of p65 and p50. However, MEPA 
treatment significantly sustained expression 
levels of p65 and p50 in the cytosolic extract by 
suppressing phosphorylation and degradation of 
IκB. These results indicate that MEPA inhibits 
LPS-induced activation of NF-κB by inhibiting the 
phosphorylation and degradation of IκB. 
 
Suppression of Akt-mediated NF-κB 
activation and MAPKs by MEPA in LPS-
stimulated BV2 microglial cells 
 
MEPA significantly decreased LPS-induced 
phosphorylation of Akt, ERK and JNK, but not 
p38 MAPK (Fig. 5A and 5B). To further ascertain 
whether NF-κB activation is involved in the 
MEPA-induced dephosphorylation of Akt, EMSA 
was performed after cells were treated with the 
Akt inhibitor LY294002. Treatment with 
LY294002 significantly reduces the DNA-binding 
activity of NF-κB (Fig. 5C). These results indicate 
that MEPA-induced NF-κB inactivation is 
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Fig 5: Effect of MEPA on LPS-induced 
phosphorylation of Akt and MAPKs. (A and B) Cells 
were treated with vehicle or the indicated 
concentrations of MEPA 1 h before stimulation with 
LPS (1.0 µg/ml) for 15 min. Total protein was 
subjected to 10% SDS-PAGE followed by western blot 
analysis with antibodies specific to the phosphorylated 
forms of Akt (A) and MAPKs (B). (C) In a parallel 
experiment, cells were incubated with LY294002 (20 
µM) for 30 min 1 h before LPS treatment, nuclear 
extracts were prepared and analyzed for DNA-binding 




Pathological agents such as bacteria and fungi 
stimulate microglia and macrophages resulting in 
the activation of mediators involved in 
inflammation [16]. Therefore, regulation of 
abnormal activation of microglia cells is a 
potential therapeutic target. In recent years, 
several researchers have attempted to identify 
compounds from marine seaweed, which exhibit 
anti-inflammatory effects in LPS-stimulated 
macrophages and microglial cells [17,18]. In this 
regard, in an attempt to identify novel anti-
inflammatory compounds from seaweeds, we 
have investigated the use of MEPA as a possible 
pharmaceutical candidate against inflammatory 
response. First, we found that MEPA reduces 
expression of the pro-inflammatory mediators NO 
and PGE2, as well as their regulatory genes 
iNOS and COX-2, in LPS-stimulated cells. In 
addition, suppression of LPS-induced NF-κB 
activation via the Akt signal pathway and MAPK 
pathways induced the anti-inflammatory effects 
of MEPA. 
 
NF-κB is known to be the most important 
transcription factor in the regulation of pro-
inflammatory genes such as iNOS and COX-2 
[19]. It is a ubiquitous protein that displays a 
rapid cellular response upon activation by LPS 
under various pathological conditions. In its 
inactive state, NF-κB exists as a heterodimer of 
p65 and p50 subunits in the cytoplasm. Once 
activated, NF-κB translocates into the nucleus 
through the phosphorylation and degradation of 
IκB, and proceeds to transcribe pro-inflammatory 
genes such as iNOS and COX-2 [15]. Our 
findings show that MEPA downregulates the 
LPS-stimulated expression of iNOS and COX-2 
by inhibiting the nuclear translocation of p65 and 
p50, resulting in the suppression of NF-κB 
activity. In a recent study, it was shown that the 
Akt pathway is directly involved in regulating NF-
κB activity to attenuate inflammatory responses 
through the degradation of IκB [20]. In this study, 
we also found that MEPA suppresses the Akt-
dependent activation of NF-κB, suggesting that 
MEPA affects the regulation of the inflammatory 
signal cascade. Nevertheless, further work is 
required to substantiate these observations in 
light of the study that revealed the role of the 
transcriptional factor AP-1 expression of pro-
inflammatory genes [21]. 
 
The MAPK signaling pathway is involved in 
inflammatory responses occurring activated 
microglial cells [22]. However, there are several 
inconsistencies in the expression of proteins of 
the MAPK family such as ERK, p38 and JNK. 
Reports suggest that ERK and p38 are essential 
for regulating LPS-induced NF-κB activation 
[23,24]. Other investigations revealed the crucial 
effects of JNK on inducing pro-inflammatory 
mediators via the NF-κB pathway [25,26]. 
Interestingly, there are yet other reports 
suggesting that none of the MAPK family has any 
influence on NF-κB activation [27]. Therefore, we 
speculate that such discrepancies arise from the 
individual properties of each compound. In this 
study, we show that MEPA significantly inhibits 
the LPS-induced phosphorylation of ERK, p38 
and JNK. However, further functional studies of 
MEPA-mediated suppression of LPS-induced 
MAPKs in the regulation of NF-κB activity are 
needed. 
 
In summary, we have established that MEPA 
inhibits the expression of NO and PGE2 in LPS-
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stimulated BV2 microglial cells through the 
suppression of their regulatory genes. In 
addition, we also show that the inhibitory effects 
of MEPA are associated with the suppression of 
Akt-dependent NF-κB activation as well as the 




Our data demonstrate that MEPA down-
regulates pro-inflammatory mediators NO and 
PGE2, and their respective regulatory genes 
iNOS and COX-2 in LPS-stimulated BV2 
microglial cells. This anti-inflammatory effect 
results from suppression of Akt-dependent NF-
κB activity as well as phosphorylation of ERK 
and JNK in LPS-stimulated BV2 microglial cells. 
Collectively, we conclude that MEPA could be a 
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